SCHEMBL80447

SCHEMBL80447

Cc1ccc(C=CC(=O)O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOS P01100 1/20 0.66
JUN P05412 1/20 0.66
HCAR2 Q8TDS4 2/20 0.65
CA12 O43570 2/20 0.65
AKR1B10 O60218 2/20 0.65
CA1 P00915 2/20 0.65
CA2 P00918 2/20 0.65
CA3 P07451 2/20 0.65
AKR1B1 P15121 2/20 0.65
CA4 P22748 2/20 0.65
CA6 P23280 2/20 0.65
DPP4 P27487 2/20 0.65
CA5A P35218 2/20 0.65
CA7 P43166 2/20 0.65
CA9 Q16790 2/20 0.65
CA14 Q9ULX7 2/20 0.65
CA5B Q9Y2D0 2/20 0.65
ESR1 P03372 1/20 0.65
PKM P14618 1/20 0.65
TYR P14679 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7905993 1.00 FOS (0.66) FOSJUNHCAR2CA12AKR1B10
SCHEMBL80446 1.00 FOS (0.66) FOSJUNHCAR2CA12AKR1B10
SCHEMBL389190 0.98 FOS (0.63) FOSJUNHCAR2CA12AKR1B10
Ammonia Solution, Strong SCHEMBL6327693 0.98 FOS (0.63) FOSJUNHCAR2CA12AKR1B10
Hydrochloric Acid SCHEMBL9445643 0.98 FOS (0.63) FOSJUNHCAR2CA12AKR1B10
Ammonia Solution, Strong SCHEMBL6327696 0.98 FOS (0.63) FOSJUNHCAR2CA12AKR1B10
Water SCHEMBL2958855 0.98 FOS (0.63) FOSJUNHCAR2CA12AKR1B10
Water SCHEMBL2958859 0.98 FOS (0.63) FOSJUNHCAR2CA12AKR1B10
SCHEMBL389191 0.98 FOS (0.63) FOSJUNHCAR2CA12AKR1B10
Hydrochloric Acid SCHEMBL27093060 0.98 FOS (0.63) FOSJUNHCAR2CA12AKR1B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1485 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079891-A Forsyqinlingine C derivative and preparation method and application thereof 2026-05-26 CN claimed
EP-4302747-B1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT OREAL (FR) 2026-01-14 EP claimed
US-12497636-B2 Recombinant Saccharomyces cerevisiae cells for cannabinoid production NATIONAL UNIVERSITY OF SINGAPORE (SG) 2025-12-16 US claimed
US-20250352444-A1 Antimicrobial mixtures SYMRISE AG (DE) 2025-11-20 US claimed
US-12365830-B2 Ligand-exchangeable janus nanoparticles and methods of making the same ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) 2025-07-22 US claimed
CN-115959962-B Visible light-promoted halogenated alkane hydrodehalogenation method 中国科学院兰州化学物理研究所 2025-05-23 CN claimed
CN-119874466-A N, N-dimethylamide compound and synthesis method thereof 海南大学 2025-04-25 CN claimed
WO-2025081932-A1 RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF 深圳市护家科技有限公司 2025-04-24 WO claimed
EP-4525822-A1 ANTIMICROBIAL MIXTURES Symrise AG (DE) 2025-03-26 EP claimed
CN-119505253-A Bio-based epoxy emulsifier, sizing agent, carbon fiber, composite material and preparation method thereof 道生天合材料科技(上海)股份有限公司 2025-02-25 CN claimed
WO-1999063333-A1 SURFACE REGENERATION OF BIOSENSORS BIACORE AB (SE) 1999-12-09 WO claimed
US-5961875-A Antifreeze/coolant composition containing cinnamic acid CCI CO., LTD. (JP) 1999-10-05 US claimed
US-5919552-A Coated substrates and methods XEROX CORPORATION (US) 1999-07-06 US claimed
US-5763128-A Simulated photographic-quality images on a substrate without curl XEROX CORPORATION (US) 1998-06-09 US claimed
EP-0783536-B1 IMPROVED PROCESS FOR THE PREPARATION OF POLYETHYLENE COPOLYMERS DU PONT (US) 1998-05-13 EP claimed
US-5223631-A Epooxidation of olefinically unsaturated substrate NATIONAL SCIENCE COUNCIL (TW) 1993-06-29 US claimed
EP-0327021-B1 COATING COMPOSITIONS FOR PREVENTING ADHESION OF AQUATIC ORGANISMS KANSAI PAINT CO. LTD. (JP) 1993-06-09 EP claimed
US-4895827-A Containing cinnamic metal salt APPLETON PAPERS INC. (US) 1990-01-23 US claimed
EP-0166542-A2 Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1986-01-02 EP claimed
EP-0154530-A2 Medicinal substance Robinson, Reuben Judah (ZA) 1985-09-11 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250352444-A1 Antimicrobial mixtures LRBA, MGLL, TAS2R50 FOS 912/4885JUN 1416/4885HCAR2 3860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.